Avestria Ventures has closed its Avestria Ventures Fund I to new investors. The venture capital fund is based in San Francisco's Bay Area. Avestria invests in women-led startups to help speed up transformation in the health sector.
The closure of Fund I is due to the sale of two of its portfolio companies this summer. Organon (NYSE: OGN), a women’s health company, bought its portfolio company Alydia Health for up to $240 million on 16 June. Following this, dietary supplement company Pharmavite bought another portfolio company Uqora for an undisclosed amount on 1 July.
“We believe that both of our focus areas – women’s health and female-led life science companies are ripe for innovation. And the two exits we’ve already had indicate that strategic investors are beginning to draw the...
